Home › Funds › Bellevue Group AG › PVLA

Bellevue Group AG position in PVLA

PALVELLA THERAPEUTICS INC NEW COM · Health Care

Bellevue Group AG reported holding 155,000 shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM) in its Q2 2026 13F filing — a position valued at US$23.7M, representing 0.50% of its reported portfolio and ranking #45 among its reported holdings. Bellevue Group AG first reported this position in Q2 2026.

Latest position (Q2 2026)155.00K sh
Reported value held$23.69M
Portfolio Weight0.50%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's PVLA position evolved

Bellevue Group AG first disclosed a stake in PVLA in Q2 2026 at 155,000 shares (US$23.7M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 155.00K $23.69M New

About PVLA and 13F data

PVLA (PALVELLA THERAPEUTICS INC NEW COM) is a Health Care company. 90 other funds we track also report a position in PVLA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$173.5M), Frazier Life Sciences Management, L.P. (US$134.8M), First Light Asset Management, LLC (US$118.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PVLA

All PVLA fund holders →

FAQ

How long has Bellevue Group AG held PVLA?

Bellevue Group AG has disclosed PVLA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Bellevue Group AG's current position in PVLA?

As of Q2 2026, Bellevue Group AG holds 155.00K shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM), valued at $23.69M, representing 0.50% of its reported portfolio and ranking #45.

Has Bellevue Group AG been buying or selling PVLA?

In the latest 13F filing (Q2 2026), Bellevue Group AG newly opened its position in PVLA.

Which other funds hold PVLA?

Other major institutional holders of PVLA include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, among 90 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.